Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

Ad­vi­sors to the FDA had dif­fi­cul­ty dis­sect­ing a small but con­cern­ing set of safe­ty da­ta from Mod­er­na’s pe­di­atric RSV vac­cine da­ta, large­ly con­clud­ing that oth­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER